The last day of trial consisted of closing arguments from both sides, and instructions on the applicable law.
Brian Panish began with Plaintiff’s closing argument. He began by thanking the court for running everything so smoothly and efficiently. He then thanked the jury for their time and commitment. Mr. Panish quoted Abraham Lincoln saying the greatest act of citizenship one can engage in is sitting on a jury, that together the individuals become the conscience of the community.
Mr. Panish reiterated that companies like DePuy make a profit by providing pain relief to patients, and in this case through orthopedic hip implants. But that with that profit, manufacturers are responsible, or strictly liable, when they put out a defective product and that product causes harm. He continued by pointing out that the Defendants rather than be held accountable, tried to switch the focus of the case to Mr. Kransky’s medical condition, and failed to explain away any of the incriminating emails, statements, and evidence of their own wrongdoing.
As to DePuy’s overarching goal as a company to profit, Mr. Panish noted that Randy Kilburn himself described the company by saying “[w]e are a competitive company, and hips and knees are a competitive market. We wanted to be a ruthless competitor.” Mr. Panish explained that while a company needs to do business for profit, there was never any talk of patient safety, that once DePuy noticed problems with the ASR and its early failure rates no one stopped to think about the patient. Instead, the employees only considered what was best for the company.
Most of Mr. Panish’s closing argument on behalf of Plaintiff Bill Kransky consisted of summarizing the causes of action at play in this case and reasoning with the jury that Plaintiff has prevailed on each and every one. He explained that DePuy is strictly liable for creating a defective product, and also for a failure to warn. He also explained how DePuy was negligent in their actions with respect to the ASR.
Mr. Panish took the jury through the liability phase of the closing argument, highlighting how defective the ASR was. He next took them through the causation elements, reasoning how as a result of the defective design of the ASR, Mr. Kransky (and numerous others) were injured. He reasoned that the ASR caused injuries to Mr. Kransky. At one point, describing DePuy’s refusal to test the ASR or hire a toxicologist Mr. Panish exclaimed “Did they test about it? Did they get a toxicologist? No. They just wanted to play Russian roulette and take the risk. Because they’re getting money. Who’s taking the risk? The patient. Not Mr. Kilburn. Not Mr. Graham Isaac. The patients. And they gambled.”
Mr. Panish also commented on the Defendants’ proffered experts, highlighting the fact that one such expert is considered the “go-to-guy” in the defense industry, the same expert who in a PG&E case regarding bad groundwater, did everything he could to help the industry despite numerous injuries to individuals. That very expert, Dr. Paustenbach, was paid $5 million to testify in the Kransky case.
Regarding DePuy’s failure to warn, Mr. Panish reiterated that a great deal of internal data existed, showing the ASR was having problems. DePuy never warned others that internal testing was showing massive wear, nor the fact that they tested the ASR at only one angle. DePuy instead created a confidential redesign project called ALPHA once the ASR began to have problems. The project was ultimately discarded as unprofitable.
Mr. Kransky’s own implanting surgeon, Dr. Wendt, testified that had he known these dangers and defective design of the ASR, he would not have used the device. That failure to warn by DePuy caused Mr. Kransky’s injuries.
As to negligence, DePuy’s own employee testified that the performance with respect to design failure modes and effects analyses was inadequate. They were negligent. Mr. Panish explained that the standard for DePuy was to roll out a metal-on-metal device that was at least as good or better than others on the market. The ASR was neither. Mr. Panish reasoned with the jury that when a company like DePuy has these problems, it should stop and go fix the design. The fact that DePuy never did so was negligent. The fact that DePuy encountered numerous red flags with respect to the ASR, but never acted on any of them, constitutes negligence.
Ultimately, Mr. Panish asked on behalf of Mr. Kransky, for economic damages (medical expenses) and non-economic damages for pain and suffering. Mr. Kransky’s medical expenses totaled $338,136.12. As to Mr. Kransky’s non-economics, Mr. Panish described the unrelenting pain he endured, unable to do anything for himself including take a shower or dress, falling in the middle of the street,and the loss of his independence generally. Mr. Panish asked the jury to award $5 million to Mr. Kransky’s for his pain and suffering.
Mr. Panish then discussed a very important element in this case, punitive damages. Punitive damages, or exemplary damages, are intended to punish for certain behavior and set an example. The fact that DePuy acted with conscious and intentional disregard of the dangers of the ASR would call for a punitive damages award. Mr. Kilburn himself admitted that if a company ignores numerous red flags, as was the case with the ASR, then the company is acting in conscious disregard for the safety of others.
Mr. Panish discussed the fact that not once throughout the trial did someone from the DePuy camp apologize for what happened with the ASR. Mr. Ekdahl, the worldwide president, refused to show up for the trial. In reasoning with the jury, Mr. Panish commented that the punitives should be something that catches the attention of these people, that DePuy needs a sound solid message sent to them. He also brought up the fact that even when DePuy finally determined the ASR to be defective and knew it was failing, rather than stop selling, the company “rationalized,” meaning they made a business decision to sell off the remaining implants. DePuy continued selling the defective ASR to be placed in numerous patients’ body, all while knowing that it was dangerous.
On the issue of numbers, Mr. Panish reasoned with the jury to choose a number that Mr. Ekdahl would notice, one that would make him take a second look and think about his shareholders, his stock options, that something needs to be done. A number that would deter DePuy and warn others against similar acts. The company is valued at 3.575 billion. This means that just one percent of the company is $36 million dollars. Mr. Panish then explained that one percent would not get anyone’s attention and that DePuy sold off an extra $24 million in the defective ASR product earlier. Only 2% of the company is $72 million. Mr. Panish said maybe DePuy would not do it a second time if they were to owe this much. But only 5% of the company amounts to $179 millions. A number that high would likely register with DePuy, or possibly 10% at $357 million. Ultimately, Mr. Panish told the jury he believed that between 2 and 5 percent would be the proper amount for punitive damages against DePuy.
Next, Mr. Zellers gave the closing argument for Defendants. He thanked the jury and court for their time. He began by telling the jury that until the time of the recall, late 2010, the reported complaints to DePuy were “very low.”
Mr. Zellers claimed that DePuy is not strictly liable in the first cause of action because the ASR’s design was not defective. He also raised the defense that Mr. Kransky’s revision was not caused by the ASR, but by infection. Mr. Zellers again raised the defense that Mr. Kransky’s ASR was implanted at a bad angle and subluxation occurred.
Mr. Zellers argued that the hip did not worsen Mr. Kransky’s overall medical condition and health. He argued that DePuy had actually performed extensive testing and development of the ASR. For these reasons, he argued that DePuy was neither strictly liable with respect to design and warnings, nor to negligence as a result of the company’s behavior.
The jury will now begin deliberations.
